New Antibiotics for Lower Respiratory Tract Infections

New Antibiotics for Lower Respiratory Tract Infections

Respiratory tract infections are frequently encountered in clinical practice. The growing incidence of antimicrobial resistance among the causative pathogens exerts sustained pressure on the existing therapeutic options. The emergence of antimicrobial resistance limits the treatment options and ofte...

Full description

Saved in:

Bibliographic Details
Main Authors:	Despoina Papageorgiou, Maria Gavatha, Dimitrios Efthymiou, Eleni Polyzou, Aristotelis Tsiakalos, Karolina Akinosoglou
Format:	Article
Language:	English
Published:	MDPI AG 2025-06-01
Series:	Microbiology Research
Subjects:	antibiotic resistance nosocomial pneumonia community-acquired pneumonia new antibiotics
Online Access:	https://www.mdpi.com/2036-7481/16/7/135
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Comparative Analysis of the Pathogen Structure in Patients with Community-Acquired and Nosocomial Pneumonia in Medical Organizations of the Rostov, Tyumen Regions and Khabarovsk Territory at the Current Stage of a New Coronavirus Infection Pandemic
by: N. V. Pavlovich, et al.
Published: (2023-10-01)

Antibiotic Therapy of Severe Community-Acquired Pneumonia
by: O. V. Molchanova, et al.
Published: (2020-05-01)

Adherence to SATS antibiotic recommendations in patients with community acquired pneumonia in Johannesburg, South Africa
by: Murimisi Mukansi, et al.
Published: (2016-04-01)

Novelties in the treatment of community-acquired and hospital-acquired pneumonia
by: Matteo Bassetti, et al.
Published: (2025-04-01)

Antibiotic Therapy of Mild Community-Acquired Pneumonia in Inpatients
by: O. V. Molchanova, et al.
Published: (2020-05-01)

Optimizing antibiotic therapy of group IV community-acquired pneumonia patients
by: Dziublyk Ya.O.
Published: (2014-06-01)

Duration of Antimicrobial Treatment in Adult Patients with Pneumonia: A Narrative Review
by: Dimitra Dimopoulou, et al.
Published: (2024-11-01)

Etiology, antibiotic susceptibility and prognostic factors of pediatric community-acquired sepsis in Addis Ababa, Ethiopia
by: Abel Abera Negash, et al.
Published: (2021-01-01)

Evaluation of the Effect of Comorbidity on the Efficacy and Safety of β-Lactam Antibiotics in Patients with Community-Acquired Pneumonia
by: O. V. Muslimova, et al.
Published: (2022-07-01)

Inhaled Antibiotics in Reanimatology: Problem State and Development Prospects (Review)
by: A. N. Kuzovlev, et al.
Published: (2018-01-01)

Community-acquired pneumonia briefly about the main. What is important to know to the physician. Based on the materials of the Russian National Congress «Man and Drug» and the III Pulmonology Summit
by: Yu. V. Evsutina
Published: (2021-06-01)

Effectiveness of Cephalosporins /Siderophore Cephalosporins Versus Meropenem as Therapy in Patients with Hospital Acquired Pneumonia
by: Palevi Ruflianasari, et al.
Published: (2025-01-01)

Current project of management guidelines of the patients with nosocomial pneumonia in adults
by: Maria A. Karnaushkina, et al.
Published: (2017-07-01)

Retrospective Analysis of the Initial Empirical Antibiotic Therapy Effectiveness for Community-Acquired Pneumonia in Young Individuals in Moscow Multidisciplinary Hospital
by: O. V. Muslimova, et al.
Published: (2022-12-01)

АНТИБАКТЕРИАЛЬНАЯ ТЕРАПИЯ ТЯЖЕЛОЙ ВНЕБОЛЬНИЧНОЙ ПНЕВМОНИИ У ВЗРОСЛЫХ: ОБЗОР РЕКОМЕНДАЦИЙ И КЛИНИЧЕСКИЕ ПРИМЕРЫ
by: С. А. Рачина, et al.
Published: (2015-06-01)

Validation of Drug Resistance in Pneumonia (DRIP) Score as Empirical Antibiotic Failure Predictor in Community-Acquired Pneumonia Patients in Cipto Mangunkusumo Hospital
by: Rohayat Bilmahdi Simanjuntak, et al.
Published: (2024-04-01)

Assessment of Aerosolized Colistin Efficacy for Nosocomial Pneumonia
by: A. N. Kuzovlev, et al.
Published: (2017-12-01)

Nafithromycin: advancements in antibiotic therapy against community-acquired pneumonia-resistant pathogens
by: Akshata Gore, et al.
Published: (2025-08-01)

PERIBRONCHIAL ADMINISTRATION OF ANTIBIOTICS IN THE INTEGRAL TREATMENT OF PNEUMONIA IN CASE OF ACUTE POISONING
by: T. P. Pinchuk, et al.
Published: (2016-08-01)

Inhaled Polymyxin in Treatment of Elderly Patients with Severe Community-Acquired Klebsiella pneumoniae-Induced Pneumonia
by: V. I. Sakharov, et al.
Published: (2020-12-01)

Can clinical findings at admission allow withholding of antibiotics in patients hospitalized for community acquired pneumonia when a test for a respiratory virus is positive?
by: Ryan Ward, et al.
Published: (2025-01-01)

Retrospective pharmacoeconomic study of antibiotic therapy in community-acquired pneumonia
by: A. A. Taube, et al.
Published: (2023-11-01)

Determinants of non-adherence to antibiotic treatment guidelines in hospitalized adults with suspected community-acquired pneumonia: a prospective study
by: Dagfinn Lunde Markussen, et al.
Published: (2024-11-01)

Antibiotic susceptibility of pathogens isolated in respiratory tract samples of recently hospitalized patients
by: Anat Reiner-Benaim, et al.
Published: (2025-03-01)

THE CLINICAL, EPIDEMIOLOGICAL AND MICROBIOLOGICAL PATTERN OF COMMUNITY-ACQUIRED PNEUMONIA IN THE KARACHAY-CHERKESS REPUBLIC
by: Palina Khalitovna Katchieva, et al.
Published: (2022-10-01)

Effects of Antibiotic De-Escalation on Outcomes in Severe Community-Acquired Pneumonia: An Inverse Propensity Score-Weighted Analysis
by: Diego Viasus, et al.
Published: (2025-07-01)

ANTIBIOTIC RESISTANCE OF KLEBSIELLA PNEUMONIAE TO CEPHALOSPORINS
by: E. V. Anganova, et al.
Published: (2017-07-01)

Comparison of initial empirical antibiotic regimens in severe community-acquired pneumonia: a network meta-analysis
by: Min Wang, et al.
Published: (2025-05-01)

Frequency of Ventilator-associated Pneumonia With 3-day Versus 7-day Ventilator Circuit Changes
by: Ting-Chang Hsieh, et al.
Published: (2010-02-01)

Bacteria isolated from lungs of sheep with pneumonia and antibiotic susceptibilities
by: Dilek Öztürk, et al.

Serum cytokine levels in children with community-acquired pneumonia caused by different respiratory pathogens
by: Yuanhui Duan, et al.
Published: (2025-05-01)

Retrospective Analysis of the Safety of Antibacterial Medicinal Products for Elderly Patients with Community-Acquired Lower Respiratory Tract Infections
by: G. I. Gorodetskaya, et al.
Published: (2023-03-01)

Features of laboratory indicators of severe community-acquired pneumonia.
by: T. A. Pertzeva, et al.
Published: (2017-06-01)

Тhe features of severe community acquired pneumonia
by: Avramenko I.V.
Published: (2015-06-01)

Vaccinal Prevention of Lower Respiratory Tract Pneumococcal Disease in Adults Without Immunosuppression
by: I. A. Guchev
Published: (2020-05-01)

Assessment of Antibiotic Use in ICU Patients with Pneumonia Using ATC/DDD as a Quantitative Analysis Method
by: Mareta Rindang Andarsari, et al.
Published: (2022-08-01)

Antibiotic Resistance and Its Molecular Mechanisms in Carbapenem-Nonsusceptible Klebsiella pneumoniae Isolated in Pediatric ICUs in Moscow
by: O. A. Kryzhanovskaya, et al.
Published: (2020-05-01)

Study of the clinical profile of community-acquired pneumonia: a cross-sectional study in northeast India
by: Annu Gupta, et al.
Published: (2025-06-01)

Evaluation of the Efficacy and Safety of Initial Empirical Antibiotic Therapy for Community-Acquired Pneumonia in Middle-Aged People
by: T. V. Alexandrova, et al.
Published: (2022-07-01)

Comparative analysis of Chlamydia pneumoniae pneumonia (CPP) and Mycoplasma pneumoniae pneumonia in children and risk factors of severe CPP
by: Yu HUANG, et al.
Published: (2025-08-01)